RMD

Over the past six months, ResMed's stock price has experienced pressure, with declines observed over 30 and 90-day periods. The stock has fallen approximately 22% year-to-date in 2026 and about 30% below its 52-week high. Key events impacting the stock include the release of its third-quarter fiscal year 2026 results, the announcement of a CFO retirement and successor appointment, and the declaration of a quarterly cash dividend. In February 2026, ResMed launched its AirTouch F30i Comfort Full Face CPAP mask in the United States.